NEW YORK – In light of the COVID-19 pandemic, the UK's National Institute for Health and Care Excellence has issued a list of interim treatment options aimed at limiting the risk of infection for cancer patients in England.
NEW YORK – In light of the COVID-19 pandemic, the UK's National Institute for Health and Care Excellence has issued a list of interim treatment options aimed at limiting the risk of infection for cancer patients in England.
Premium Access gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a Precision Oncology News or 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.